Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation

Clinical Science

Volumn 114, Issue 3-4, 2008, Pages 321-329

  Enkhbaatar, Perenlei ^a   Esechie, Aimalohi ^a   Wang, Jianpu ^a   Cox, Robert A ^a   Nakano, Yoshimitsu ^a   Hamahata, Atsumori ^a   Lange, Matthias ^a   Traber, Lillian D ^a   Prough, Donald S ^a   Herndon, David N ^b   Traber, Daniel L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome (ARDS); Antithrombin; Burn; Heparin; Smoke inhalation

Indexed keywords

ANTICOAGULANT AGENT; HALOTHANE; HEPARIN; RECOMBINANT ANTITHROMBIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ANTITHROMBIN; FIBRINOLYTIC AGENT; NITRIC OXIDE; PEROXIDASE; RECOMBINANT PROTEIN; VASCULOTROPIN A;

ACUTE LUNG INJURY; AEROSOL; AIRWAY OBSTRUCTION; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; BODY SURFACE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOLOGY; INSPIRATORY CAPACITY; LEUKOCYTE; LUNG BURN; LUNG EDEMA; LUNG FLUID; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG LYMPH FLOW; LUNG PARENCHYMA; LUNG VENTILATION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SHEEP; VENTILATOR; ANIMAL; BURN; COMPARATIVE STUDY; HUMAN; IMMUNOLOGY; INJURY; INTRAVENOUS DRUG ADMINISTRATION; LUNG; METABOLISM; PATHOLOGY; SKIN;

AEROSOLS; ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; BURNS; BURNS, INHALATION; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; LEUKOCYTES; LUNG; MODELS, ANIMAL; NITRIC OXIDE; PEROXIDASE; PULMONARY EDEMA; RECOMBINANT PROTEINS; RESUSCITATION; SHEEP; SKIN; SMOKE INHALATION INJURY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38949196514     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070254     Document Type: Article

References (42)

1. Olson, S. T., Bjork, I. and Shore, J. D. (1993) Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol. 222, 525-559
2. Okajima, K. and Uchiba, M. (1998) The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin. Thromb. Hemostasis 24, 27-32
3. Souter, P. J., Thomas, S., Hubbard, A. R., Poole, S., Romisch, J. and Gray, E. (2001) Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit. Care Med. 29, 134-139
4. Isobe, H., Okajima, K., Uchiba, M., Harada, N. and Okabe, H. (2002) Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats. Blood 99, 1638-1645
5. Kaneider, N. C., Egger, P., Dunzendorfer, S. and Wiedermann, C. (2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun. 287, 42-46
6. Harada, N., Okajima, K., Isobe, H. and Uchiba, M. (2006) Antithrombin reduces endotoxin-induced hypotension by enhancing pulmonary sensory neuron activation in rats. Thromb. Haemostasis 95, 1011-1018
7. Garcla-Avello, A., Lorente, J. A., Cesar-Perez, J. et al. (1998) Hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb. Res. 89, 59-64
8. Kowal-Vern, A., McGill, V., Walenga, J. M. and Gameli, R. L. (2000) Antithrombin III concentrate in the acute phase of thermal injury. Burns 26, 97-101
9. Aoki, K., Aikawa, N., Sekine, K. et al. (2001) Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns. Burns 27, 569-575
10. Niedermayr, M., Schramm, W., Kamolz, L. et al. (2007) Antithrombin deficiency and its relationship to severe burns. Burns 33, 173-178
11. Enkhbaatar, P., Murakami, K., Shimoda, K. et al. (2003) The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am. J. Respir. Crit. Care Med. 167, 1021-1026
12. Enkhbaatar, P., Murakami, K., Shimoda, K. et al. (2003) Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury. Am. J. Physiol. Heart Circ. Physiol. 285, H2430-H2436
13. Cox, R. A., Burke, A. S., Soejima, K. et al. (2003) Airway obstruction in sheep with burn and smoke inhalation injuries. Am. J. Respir. Cell. Mol. Biol. 29, 295-302
14. Pearce, M. L., Yamashita, J. and Beazell, J. (1965) Measurement of pulmonary edema. Circ. Res. 16, 482-488
15. Hollingsworth, J. W., Chen, B. J., Brass, D. M. et al. (2005) The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am. J. Respir. Crit. Care Med. 171, 806-813
16. Mineta, H., Miura, K., Ogino, T. et al. (2000) Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br. J. Cancer 83, 775-781
17. Soejima, K., Traber, L. D., Schmalstieg, F. C. et al. (2001) Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am. J. Respir. Crit. Care Med. 163, 745-752
18. Sakurai, H., Schmalstieg, F. C., Traber, L. D., Hawkins, H. K. and Traber, D. L. (1999) Role of L-selectin in physiological manifestations after burn and smoke inhalation injury in sheep. J. Appl. Physiol. 86, 1151-1159
19. Enkhbaatar, P., Murakami, K., Cox, R. et al. (2004) Aerosolized tissue plasminogen activator improves pulmonary function in sheep with burn and smoke Inhalation. Shock 22, 70-75
20. Olson, S. T. and Bjork, I. (1991) Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J. Biol. Chem. 266, 6353-6364
21. Olson, S. T., Bjork, I., Sheffer, R. et al. (1992) Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J. Biol. Chem. 267, 12528-12538
22. Warren, B., Eid, A., Singer, P. et al. (2001) High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA, J. Am. Med. Assoc. 286, 1869-1878
23. Murakami, K., McGuire, R., Cox, R. A. et al. (2002) DL. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 18, 236-241
24. Pata, C., Caglikulekci, M., Cinel, L., Dirlik, M., Colak, T. and Aydin, S. (2002) The effects of antithrombin-III on inducible nitric oxide synthesis in experimental obstructive jaundice. Pharmacol. Res. 46, 325-331
25. Lee, W. L. and Downey, G. P. (2001) Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care 7, 1-7
26. Parsey, M. V., Tuder, R. M. and Abraham, E. (1998) Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J. Immunol. 160, 1007-1013
27. Shenkar, R. and Abraham, E. (1999) Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-κB, and cyclic AMP response element binding protein. J. Immunol. 163, 954-962
28. Maris, N. A., de Vos, A. F., Dessing, M. C. et al. (2005) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am. J. Respir. Crit. Care Med. 172, 878-884
29. Katahira, J., Murakami, K., Schmalstieg, F. C. et al. (2002) Role of anti-L-selectin antibody in burn and smoke inhalation inury in sheep. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L1043-L1050
30. Oelschlager, C., Romisch, J. and Staubitz, A. et al. (2002) Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells. Blood 99, 4015-4020
31. Kaneider, N. C., Reinisch, C. M., Dunzendorfer, S., Romisch, J., Wiedermann, C. J. and Wiederman, C. J. (2002) Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell Sci. 115, 227-236
32. Fujii, E., Irie, K., Ogawa, A., Ohba, K. and Muraki, T. (1996) Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol. 297, 257-263
33. Brkovic, A. and Sirois, M. G. (2007) Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. J. Cell. Biochem. 100, 727-737
34. Yano, K., Liaw, P. C., Mullington, J. M. et al. (2006) Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J. Exp. Med. 203, 1447-1458
35. Dvorak, H. F., Nagy, J. A., Feng, D. and Brown, L. F. (1999) Vascular permeability factor, vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Topics Microbiol. Immunol. 237, 97-132
36. Schoch, H. J., Fischer, S. and Marti, H. H. (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125, 2549-2557
37. Madjdpour, C., Jewell, U. R., Kneller, S. et al. (2003) Decreased alveolar oxygen induces lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L360-L367
38. +-ATPase. Am. J. Respir. Cell. Mol. Biol. 33, 343-354
39. Levy, A. P., Levy, N. S., Wegner, S. and Goldberg, M. A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333-13340
40. Bernard, G. R., Vincent, J. L., Laterre, P. F. et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699-709
41. Laterre, P. F., Wittebole, X. and Dhainaut, J. F. (2003) Anticoagulant therapy in acute lung injury. Crit. Care Med. 31, S329-S336
42. Jacobson, J. R. and Garcia, J. G. (2007) Novel therapies for microvascular permeability in sepsis. Curr. Drug Targets 8, 509-514